La Verde, Nicla
Damia, Giovanna
Garrone, Ornella
Santini, Daniele
Fabi, Alessandra
Ciccarese, Mariangela
Generali, Daniele Giulio
Nunzi, Martina
Poletto, Elena
Ferraris, Elisa
Cretella, Elisabetta
Scandurra, Giuseppa
Meattini, Icro
Bertolini, Alessandro Stefano
Cavanna, Luigi
Collovà, Elena
Romagnoli, Emanuela
Rulli, Eliana
Legramandi, Lorenzo
Guffanti, Federica
Bramati, Annalisa
Moretti, Anna
Cassano, Alessandra
Vici, Patrizia
Torri, Valter
Farina, Gabriella
,
Article History
Received: 2 February 2022
Accepted: 19 September 2022
First Online: 28 October 2022
Declarations
:
: The study was approved in the center of the principal investigator at Fatebenefratelli Hospital in Milan, Italy. The Ethical Committee was “Comitato Etico Milano Area B.” The approval was obtained on December10th, 2013. Every patient signed a written informed consent previously approved by ethical committee. The research was carried out in accordance with the Declaration of Helsinki.
: Not applicable.
: NLV Eisai, MSD, Roche, Novartis, Astrazeneca, GSK, Pfizer, Gentili, Celgene. GD no competing interests. OG Eisai, MSD, Pierre Fabre, Seagen, Gilead, Novartis. DS Astrazeneca, Novartis, LILT, University of Trieste, Lilly, Pfizer, Roche, Istituto Gentili. AF Astrazeneca, Celgene, Dompè, Eisai, Lilly, Novartis, Pfizer, Roche, Pierre, Fabre. MC no competing interests. DGG Astrazeneca, Novartis, LILT, University of Trieste, Lilly, Pfizer, Roche, Novartis, Istituto Gentili. MN no competing interests. EP no competing interests. EF no competing interests. EC no competing interests. GS no competing interests. IM Eli Lilly, Novartis, Istituto Gentili, Roche, Pfizer, Ipsen, and Pierre Fabre.. ASB no competing interests. LC Astrazeneca, Pfizer, Ipsen, Celgene. EC no competing interests. ER no competing interests. ER no competing interests. LL no competing interests. FG no competing interests. AB Astellas, Jansenn, GSK. AM Sophosbiotech, Janssen. AC Novartis. PV Eisai, Roche, Pfizer, Novartis, Istituto Gentili. VT no competing interests. GF no competing interests.